|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0693 USD | -0.55% |
|
+0.43% | +23.97% |
Quotes 5-day view: Provectus Biopharmaceuticals, Inc.
Delayed Quote OTC Markets| 2026-07-02 | 2026-07-06 | 2026-07-07 | 2026-07-08 | 2026-07-09 | |
|---|---|---|---|---|---|
| Last | US$0.0690 | US$0.0688 | US$0.0670 | US$0.0697 | US$0.0693 |
| Volume | 66,450 | 41,590 | 378,599 | 352,220 | 615,683 |
| Change | -0.87% | -0.29% | -2.62% | +4.03% | -0.55% |
| Opening | US$0.0644 | US$0.0690 | US$0.0682 | US$0.0684 | US$0.0700 |
| High | US$0.0698 | US$0.0697 | US$0.0698 | US$0.0699 | US$0.0767 |
| Low | US$0.0644 | US$0.0682 | US$0.0670 | US$0.0684 | US$0.0629 |
Performance
| 1 day | -0.55% | ||
| 1 week | +0.43% | ||
| Current month | -0.14% | ||
| 1 month | +2.82% | ||
| 3 months | +24.86% | ||
| 6 months | +11.77% | ||
| Current year | +23.97% | ||
| 1 year | -8.33% | ||
| 3 years | -42.30% | ||
| 5 years | -1.00% | ||
| 10 years | -79.32% |
Volumes
marketsDaily volume
615,683
Estimated daily volume
615,683
Avg. Volume 20 sessions
166,046
Daily volume ratio
3.71
Avg. Volume 20 sessions USD
11,510.31
Record volume 1
30,514,325
Record volume 2
27,044,540
Record volume 3
26,314,440
Capital turnover ratio
0
Float rotation
0
Basic data
Market Cap (USD)
29,293,507
Net sales ()
0
Number of employees
6
Sales / Employee ()
0
Sales / Employee (USD)
0
Free-Float
92.52 %
Free-Float capitalization (USD)
27,101,202
Average Daily Capital Traded
0.04%
Indicators
Moving average 5 days
0.0688
Moving average 20 days
0.0666
Moving average 50 days
0.0648
Moving average 100 days
0.0586
Price spread / (MMA5)
-0.75%
Price spread / (MMA20)
-3.92%
Price spread / (MMA50)
-6.52%
Price spread / (MMA100)
-15.46%
STIM
RSI 9 days
59.52
RSI 14 days
57.53
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.55% | +0.43% | -8.33% | -42.30% | 29.29M | ||
| -0.38% | -3.44% | +71.35% | +128.83% | 56.71B | ||
| +4.91% | -0.19% | +73.70% | +92.14% | 51.3B | ||
| +1.48% | +5.97% | +22.59% | +495.47% | 25.26B | ||
| -0.59% | -4.68% | -16.82% | -12.99% | 23.65B | ||
| +6.26% | +4.85% | +53.23% | +3.63% | 18.69B | ||
| +2.01% | +2.99% | +40.72% | -24.93% | 17.71B | ||
| -6.84% | +2.18% | +203.03% | +348.11% | 17.7B | ||
| +6.74% | +1.30% | +50.54% | - | 14.26B | ||
| +1.76% | +2.24% | +29.57% | +195.70% | 14.1B | ||
| Average | +1.45% | +2.26% | +51.96% | +131.52% | 23.94B | |
| Weighted average by Cap. | +1.68% | +0.75% | +60.34% | +145.62% |
Historical Quotes: Provectus Biopharmaceuticals, Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Latest transactions
9475dbb5a3d1a5cd471d530788.eaHHtR58qQtjCO1sziWATW06oD1O6253t3LYBxfyNaE.PvOk4lYv2FEse4Abt1T4eQAJ8FYMsT9F_EWdbG6KevgJ4PLdTg7KTwFRqA
| Date | Price | Volume | Total |
|---|---|---|---|
| 15:59:25 | 0.0693 | 1,000 | 615,593 |
| 15:13:19 | 0.0692 | 10,000 | 614,593 |
| 15:12:00 | 0.0700 | 20,000 | 604,593 |
| 15:10:33 | 0.0699 | 20,000 | 584,593 |
| 15:10:33 | 0.0699 | 10,250 | 564,593 |
| 15:10:32 | 0.0699 | 30,000 | 554,343 |
| 15:07:44 | 0.0691 | 10,000 | 524,343 |
| 15:07:44 | 0.0691 | 10,000 | 514,343 |
| 15:06:50 | 0.0699 | 20,000 | 504,343 |
| 15:04:59 | 0.0699 | 20,000 | 484,343 |
Course Extremes
| 1 week | 0.06 | 0.08 | |
| 1 month | 0.06 | 0.08 | |
| Current year | 0.04 | 0.08 | |
| 1 year | 0.04 | 0.1 | |
| 3 years | 0.04 | 0.22 | |
| 5 years | 0.03 | 0.22 | |
| 10 years | 0.01 | 0.35 |
Monthly variations
Annual variations
| 2026 | +24.01% | ||
| 2025 | -53.46% | ||
| 2024 | +25.10% | ||
| 2023 | -11.36% | ||
| 2022 | +96.91% | ||
| 2021 | -5.82% | ||
| 2020 | -7.89% | ||
| 2019 | +26.80% | ||
| 2018 | -39.02% | ||
| 2017 | +318.37% | ||
| 2016 | -94.97% | ||
| 2015 | -51.25% | ||
| 2014 | -66.80% | ||
| 2013 | +330.36% | ||
| 2012 | -30.86% | ||
| 2011 | -13.83% | ||
| 2010 | +3.30% | ||
| 2009 | -1.09% | ||
| 2008 | -46.51% | ||
| 2007 | +44.54% | ||
| 2006 | +32.22% | ||
| 2005 | +36.36% | ||
| 2004 | -34.65% | ||
| 2003 | +260.71% | ||
| 2002 | -74.55% |
- Stock Market
- Stocks
- PVCT Stock
- Quotes Provectus Biopharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
















